How to Use ACE-031
Complete guide to ACE-031 dosing, administration, timing, and protocol recommendations.
Quick Overview
ACE-031 was an experimental muscle-building drug, technically a fusion protein that joins the activin receptor type IIB to the Fc portion of an antibody, designed to mop up myostatin and related growth-limiting signals from the bloodstream. It was developed by Acceleron Pharma and tested in boys with Duchenne muscular dystrophy with the goal of preserving muscle. It is not approved, and its development was stopped over safety concerns, so it exists today only as a discontinued investigational compound.
Dosing Guidelines
Common Dose
Limited community data available
Frequency
See research protocols
Dose Range
See research dosing
Note: Limited anecdotal data. Refer to research dosing section.
Administration Method
Subcutaneous injection
Best Time to Take
Morning, same day each week
ACE-031 is a myostatin inhibitor with weekly dosing. Morning allows for monitoring.
Protocol Duration
Trials discontinued
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Nosebleeds
- •Gum bleeding
- •Spider veins (telangiectasias)
- •Injection site reactions
- •FSH level decrease
Frequently Asked Questions
What is the recommended dose for ACE-031?
Limited community data available
How do you administer ACE-031?
Subcutaneous injection
When is the best time to take ACE-031?
Morning, same day each week
How long should you use ACE-031?
Trials discontinued
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.